Enteris BioPharma, Inc is a leading partner in the development and manufacture of oral BCS-III and BCS-IV drug products, specializing in oral peptides, peptidomimetics, and small molecules. Their innovative Peptelligence and ProPerma technologies have been extensively tested in clinical trials, offering safe and effective oral delivery options for challenging compounds where none previously existed.
With their state-of-the-art facility in Boonton, NJ, Enteris provides end-to-end solutions for oral drug product development, including formulation, proof-of-concept, and clinical and commercial manufacturing. Their expertise in enhancing both permeability and solubility of compounds makes them a preferred partner for pharmaceutical companies seeking to bring challenging APIs to market.
Generated from the website